ANGELA KORB: Open Payments
NPI 1407251259 · SALISBURY, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$256 in 12 payments from 5 companies in 2025. Trend: 2023 $1,166 · 2024 $962 · 2025 $256
Food & beverage: $256
| Company | Payments | Amount |
|---|---|---|
| REVANCE THERAPEUTICS, INC. | 5 | $107 |
| MERZ NORTH AMERICA, INC. | 2 | $64 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 3 | $48 |
| Novartis Pharmaceuticals Corporation | 1 | $23 |
| Galderma Laboratories, L.P. | 1 | $16 |
Products named: DAXXIFY, Xeomin, LifeVest, LEQVIO.
Industry payments across MD — which companies pay providers there.
